BioSpectrum

The business of life sciences.

[BioSpectrum @BioSpectrum]

Eisai expands agreement with Arena for lorcaserin: Eisai has agreement to market and supply Lorcaserin, an inves... http://t.co/A9okULN4

[BioSpectrum @BioSpectrum]

FDA body supports approval of Gileads Truvada for HIV prevention: The Antiviral Drugs Advisory Committee of the ... http://t.co/B0f5Thyg

[BioSpectrum @BioSpectrum]

HeartWare International posts 47% growth: HeartWare International posted a revenue of $26.3 million for the firs... http://t.co/ywhL8M65

[BioSpectrum @BioSpectrum]

Daiichi Sankyo falls short of predictions in fiscal ending March 2012: A statement released by the company said ... http://t.co/2ev0UkTg

[BioSpectrum @BioSpectrum]

Biobanking application market was $818 mn in 2011: The global automation market for biobanking applications acco... http://t.co/r5V4kQsy

[BioSpectrum @BioSpectrum]

WuXi PharmaTech reports 26.2% revenue growth in Q1 2012: While manufacturing services net revenues of the compan... http://t.co/kXERFvAV

[BioSpectrum @BioSpectrum]

Thermo Fisher launches online consumables catalog with links to Facebook, Twitter: Thermo Fisher Scientific laun... http://t.co/O0IIuXA4

[BioSpectrum @BioSpectrum]

Glycomimetics to cure AIDS: The International AIDS Vaccine Initiative (IAVI), GlycoMimetics (GMI), and Glycosens... http://t.co/IOxxs5Km

[BioSpectrum @BioSpectrum]

Thermo Fisher Scientific wins 2011 Global Frost & Sullivan Company of the Year Award: Frost & Sullivan acknowled... http://t.co/75qYbQjQ

[BioSpectrum @BioSpectrum]

Sandoz to emphasize on consistent regulations across all biologics: Dr Mark McCamish, head, global biopharmaceut... http://t.co/k5Eb6FwN

[BioSpectrum @BioSpectrum]

Ella Foundation Receives $100,000 Grant for Polio: The Ella Foundation announced that it has won $100,000 Grand ... http://t.co/Qy9qRipn

[BioSpectrum @BioSpectrum]

TB now a notifiable disease: In an important move to help combat tuberculosis (TB), the government of India has ... http://t.co/ruLaneMy

[BioSpectrum @BioSpectrum]

Eppendorf launches tissue culture consumables in India: Eppendorf India, the Indian arm of Eppendorf AG, Germany... http://t.co/TrVVz8ZE

[BioSpectrum @BioSpectrum]

Teva representative joins Mesoblast board: Global regenerative medicine company Mesoblast today announced the ap... http://t.co/oRfEC1id

[BioSpectrum @BioSpectrum]

Immuron and IntegraMed Asia sign Travelan agreement: Australian biopharmaceutical company Immuron Limited entere... http://t.co/XSrNqRHf

[BioSpectrum @BioSpectrum]

ICMR to commercialize TB technologies: In order to stregthen the anti tuberculosis (TB) measures, the Indian Cou... http://t.co/jfdelSYe

[BioSpectrum @BioSpectrum]

No fresh tax sops to biotech industry, says Indian minister: While reiterating the government plan to bring in r... http://t.co/aer89OK3

[BioSpectrum @BioSpectrum]

Pfizer drug Lyrica fails ph III trial for HIV neuropathy: Pfizer has stopped a phase III clinical trial of Lyric... http://t.co/ToBNno5R

[BioSpectrum @BioSpectrum]

Takeda, Lunbeck report data on investigational compound for depression: H Lundbeck and Takeda Pharmaceutical Glo... http://t.co/iaFo1pjR

[BioSpectrum @BioSpectrum]

Oramed awarded grant by OCS: Oramed was awarded a government grant worth around $540,000 (NIS 2 million), by the... http://t.co/eWOV5vcD